Design and Rationale of the APPELHUS Phase 3 Open-Label Study of Factor B Inhibitor Iptacopan for Atypical Hemolytic Uremic Syndrome
Kidney International Reports（2023）
摘要
APPELHUS will determine if iptacopan is safe and efficacious in patients with aHUS.
更多查看译文
关键词
inhibitor,open-label
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要